Literature DB >> 6371345

Modification of pancreatic carcinogenesis in the hamster model. VIII. Inhibitory effect of exogenous insulin.

P M Pour, K Stepan.   

Abstract

The effect of exogenous insulin, which has been known to suppress beta-cell function of islets, was investigated on pancreatic carcinogenesis induced by N-nitrosobis(2-oxopropyl) amine [(BOP) CAS: 60599-38-4; 2,2'-dioxo-N-nitrosodipropylamine]. Three groups of Syrian golden hamsters were treated sc once with BOP (20 mg/kg body wt) simultaneously with (group 1), 120 minutes before (group 2), or 120 minutes after (group 3) a single sc injection of porcine insulin (5 U/kg body wt). Group 4 was a BOP-treated control. Survivors were killed 46 weeks after BOP administration, and the pancreas, common duct, and gallbladder were examined histologically. When given 120 minutes before or after BOP, insulin inhibited the induction of benign and malignant pancreatic lesions in a statistically significant fashion. However, the simultaneous administration of BOP also led to similar (although not statistically significant) results as did the administration of insulin 120 minutes after BOP. Insulin also seemed to inhibit tumor induction in the common duct and gallbladder, regardless of when it was administered; however, the differing incidence was statistically significant only in hamsters from group 3 killed at the experiment's end. The overall data suggest that the inhibitory effect of exogenous insulin on pancreatic carcinogenicity is not merely through islet cells, but rather through other (or additional) mechanisms.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6371345

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  7 in total

1.  Diabetic ketoacidosis in type 2 diabetics: a novel presentation of pancreatic adenocarcinoma.

Authors:  Ming Valerie Lin; Gene Bishop; Maria Benito-Herrero
Journal:  J Gen Intern Med       Date:  2010-01-30       Impact factor: 5.128

2.  Alterations in pancreatic islet function produced by carcinogenic nitrosamines in the Syrian hamster.

Authors:  P F Zucker; M C Archer
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

3.  Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort.

Authors:  Rachael Z Stolzenberg-Solomon; Catherine Schairer; Steve Moore; Albert Hollenbeck; Debra T Silverman
Journal:  Am J Clin Nutr       Date:  2013-08-28       Impact factor: 7.045

Review 4.  Vitamin D and pancreatic cancer.

Authors:  Rachael Z Stolzenberg-Solomon
Journal:  Ann Epidemiol       Date:  2008-05-27       Impact factor: 3.797

5.  Diagnosis of pancreatic cancer. Alteration of glucose metabolism.

Authors:  J Permert; J Larsson; I Ihse; P M Pour
Journal:  Int J Pancreatol       Date:  1991

6.  Obesity and risk of pancreatic cancer among postmenopausal women: the Women's Health Initiative (United States).

Authors:  J Luo; K L Margolis; H-O Adami; A LaCroix; W Ye
Journal:  Br J Cancer       Date:  2008-07-15       Impact factor: 7.640

Review 7.  The relationship between diabetes and pancreatic cancer.

Authors:  Feng Wang; Margery Herrington; Jörgen Larsson; Johan Permert
Journal:  Mol Cancer       Date:  2003-01-06       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.